Arkin Bio Ventures
Herzliyaarkin-capital.com
Overview
Arkin Bio Ventures is a venture capital firm based in Israel that identifies and invests in innovative early and mid-stage companies with breakthroughs in areas such as immunotherapy, cancer, metabolism, and drug-delivery platforms.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Bionyra Pharma | Jun 2026 | Series A | Co-investor |
| Ambros Therapeutics, Inc. | Dec 2025 | Series A | Co-investor |
| Auron Therapeutics | Feb 2025 | Series B | Co-investor |
| Bluejay Therapeutics | May 2024 | Series C | Co-investor |
| Entact Bio | Dec 2022 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.